Newcastle Laboratories

Levetiracetam

Clinical Background:

Therapeutic drug monitoring

Therapeutic drug monitoring

Test Details

  • Discipline:

    Biochemistry

    Biochemistry

  • Specimen Container Adult:

    EDTA plasma

    Gel tube unsuitable

    EDTA plasma

    Gel tube unsuitable

  • Specimen Container Paediatric:

    EDTA plasma

    Gel tube unsuitable

    EDTA plasma

    Gel tube unsuitable

  • Minimum Volume Adult:

    1 mL 

    1 mL 

  • Minimum Volume Paediatric:

    0.5 mL

    0.5 mL

  • Special Requirement:

    Please note that brivaracetam interferes in this assay. This assay should not be used in patients undergoing a switch in drug therapy involving levetiracetam and brivaracetam.

    Please note that brivaracetam interferes in this assay. This assay should not be used in patients undergoing a switch in drug therapy involving levetiracetam and brivaracetam.

  • Sample Stability:

    Store at 4°C

    Store at 4°C

  • Transport Requirements:

    First class post

    First class post

  • Routine Contact Name:

    Duty Biochemist

  • Routine Telephone:

    Freeman: 0191 244 8889
    RVI: 0191 282 9719

    Freeman: 0191 244 8889
    RVI: 0191 282 9719

  • Routine Email:

Availability:

Sample sent to an external laboratory for testing.

Turn Around:

2 weeks

View all tests